Fredag 27 December | 19:27:51 Europe / Stockholm

Prenumeration

Kalender

Tid*
2025-10-24 07:00 Kvartalsrapport 2025-Q3
2025-07-18 07:00 Kvartalsrapport 2025-Q2
2025-05-15 N/A Årsstämma
2025-05-06 07:00 Kvartalsrapport 2025-Q1
2025-02-13 07:00 Bokslutskommuniké 2024
2024-10-24 - Kvartalsrapport 2024-Q3
2024-07-23 - Kvartalsrapport 2024-Q2
2024-05-23 - X-dag ordinarie utdelning SEDANA 0.00 SEK
2024-05-22 - Årsstämma
2024-04-25 - Kvartalsrapport 2024-Q1
2024-02-15 - Bokslutskommuniké 2023
2023-10-26 - Kvartalsrapport 2023-Q3
2023-07-21 - Kvartalsrapport 2023-Q2
2023-05-17 - X-dag ordinarie utdelning SEDANA 0.00 SEK
2023-05-16 - Årsstämma
2023-04-27 - Kvartalsrapport 2023-Q1
2023-02-16 - Bokslutskommuniké 2022
2022-10-25 - Kvartalsrapport 2022-Q3
2022-07-21 - Kvartalsrapport 2022-Q2
2022-05-12 - X-dag ordinarie utdelning SEDANA 0.00 SEK
2022-05-11 - Årsstämma
2022-04-28 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-11-04 - Kvartalsrapport 2021-Q3
2021-08-19 - Kvartalsrapport 2021-Q2
2021-05-26 - Split SEDANA 1:4
2021-05-11 - X-dag ordinarie utdelning SEDANA 0.00 SEK
2021-05-10 - Årsstämma
2021-05-06 - Kvartalsrapport 2021-Q1
2021-02-25 - Bokslutskommuniké 2020
2020-11-05 - Kvartalsrapport 2020-Q3
2020-08-25 - Kvartalsrapport 2020-Q2
2020-05-20 - X-dag ordinarie utdelning SEDANA 0.00 SEK
2020-05-19 - Årsstämma
2020-05-07 - Kvartalsrapport 2020-Q1
2020-03-05 - Bokslutskommuniké 2019
2019-11-13 - Kvartalsrapport 2019-Q3
2019-08-22 - Kvartalsrapport 2019-Q2
2019-05-29 - X-dag ordinarie utdelning SEDANA 0.00 SEK
2019-05-28 - Årsstämma
2019-05-08 - Kvartalsrapport 2019-Q1
2019-03-21 - Bokslutskommuniké 2018
2018-11-22 - Kvartalsrapport 2018-Q3
2018-08-30 - Kvartalsrapport 2018-Q2
2018-05-23 - X-dag ordinarie utdelning SEDANA 0.00 SEK
2018-05-22 - Årsstämma
2018-05-22 - Kvartalsrapport 2018-Q1
2018-03-27 - Bokslutskommuniké 2017
2017-11-30 - Kvartalsrapport 2017-Q3

Beskrivning

LandSverige
ListaMid Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Sedana Medical är verksamt inom medicinteknik. Bolaget arbetar idag med AnaConDa-teknologi, vilket innefattar transformeringen av flytande vätska till gas. Tekniken används vanligtvis för intensivvårdspatienter vid nedsövning och skiljer sig gentemot den traditionella behandlingen som tidigare utgetts intravenöst med läkemedel. Bolaget har sitt huvudkontor i Danderyd.
2024-11-05 08:00:00

According to the principles for the appointment of the Nomination Committee in Sedana Medical AB (publ), the Nomination Committee for the Annual General Meeting 2025 shall be composed of members appointed by the three largest shareholders, along with the Chairman of the Board of Directors.

The composition of Sedana Medical´s Nomination Committee ahead of the 2025 Annual General Meeting was announced in a press release on 18 October 2024. As a result of a subsequent change in ownership, the composition of the Nomination Committee has changed with Monica Åsmyr (appointed by Swedbank Robur Fonder) leaving the Nomination Committee and Erik Durhan (appointed by Lannebo Fonder) joining as a new member of the Nomination Committee.

Accordingly, the Nomination Committee ahead of the 2025 Annual General Meeting consists of the following members:

  • Karl Tobieson, appointed by Linc AB
  • Patrik Walldov, appointed by Anders Walldov (including indirect holding via Brohuvudet AB)
  • Erik Durhan, appointed by Lannebo Fonder
  • Claus Bjerre, Chairman of the Board

The Nomination Committee shall submit proposals for resolution by the 2025 General Meeting pertaining to the election of Chairman of the Meeting, fees and composition of the Board, auditors’ fees and the election of auditors and, if necessary, proposal for changes in the instruction to the Nomination Committee.

The Nomination Committee’s proposals will be presented in the Notice to the Annual General Meeting 2025 and on Sedana Medical’s website, www.sedanamedical.com.

Shareholders wishing to submit proposals to Sedana Medical’s Nomination Committee can do so by sending an e-mail to info@sedanamedical.com (subject “Nomination Committee”) or by letter posted to Sedana Medical AB (publ), Attn: Sedana Medical Nomination Committee, Svärdvägen 3A, SE-182 33, Danderyd, Sweden. A proposal must reach the Nomination Committee no later than March 27, 2025, to be included in the notice to attend and the agenda for the annual general meeting.